Economic evaluation of artesunate and three quinine regimens in the treatment of severe malaria in children at the Ebolowa Regional Hospital-Cameroon: a cost analysis

Table 11 Calculation of incremental cost effectiveness ratio

Treatment alternative	Cost ($)	Effect (PRR₂₄)	Incremental cost ($)	Incremental effect (PRR₂₄)	ICER ($ per PRR₂₄)	Comment
QLD	51.45	0.8384				Baseline (B)
QNLD2	52.88	0.7987	1.43	−0.0397	36.020	Extended dominated
ARTES	57.85	0.9752	4.97	0.1765	28.159	Comparator (A)
QNLD3	58.18	0.7543	0.33			Dominated

$ICER = \frac{{{\text{Cost}} {\text{A}} - {\text{Cost}} {\text{B}}}}{{{\text{Effect A}} - {\text{Effect}} {\text{B}}}} = \frac{57.85 - 51.45}{0.9752 - 0.8384} = \frac{6.4}{0.1368} = \, 46.78\$ /{\text{PRR}}_{24}$

ISSN: 1475-2875